These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22796065)

  • 1. Proteome alterations in response to aristolochic acids in experimental animal model.
    Rucevic M; Rosenquist T; Breen L; Cao L; Clifton J; Hixson D; Josic D
    J Proteomics; 2012 Dec; 76 Spec No.():79-90. PubMed ID: 22796065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics analysis of altered proteins in kidney of mice with aristolochic acid nephropathy using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method.
    Lin CE; Chang WS; Lee JA; Chang TY; Huang YS; Hirasaki Y; Chen HS; Imai K; Chen SM
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29088495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
    Chen CH; Dickman KG; Huang CY; Moriya M; Shun CT; Tai HC; Huang KH; Wang SM; Lee YJ; Grollman AP; Pu YS
    Int J Cancer; 2013 Jul; 133(1):14-20. PubMed ID: 23292929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool.
    Poon SL; Pang ST; McPherson JR; Yu W; Huang KK; Guan P; Weng WH; Siew EY; Liu Y; Heng HL; Chong SC; Gan A; Tay ST; Lim WK; Cutcutache I; Huang D; Ler LD; Nairismägi ML; Lee MH; Chang YH; Yu KJ; Chan-On W; Li BK; Yuan YF; Qian CN; Ng KF; Wu CF; Hsu CL; Bunte RM; Stratton MR; Futreal PA; Sung WK; Chuang CK; Ong CK; Rozen SG; Tan P; Teh BT
    Sci Transl Med; 2013 Aug; 5(197):197ra101. PubMed ID: 23926199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prednisolone on glyoxalase 1 in an inbred mouse model of aristolochic acid nephropathy using a proteomics method with fluorogenic derivatization-liquid chromatography-tandem mass spectrometry.
    Chen SM; Lin CE; Chen HH; Cheng YF; Cheng HW; Imai K
    PLoS One; 2020; 15(1):e0227838. PubMed ID: 31968011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective toxicity of aristolochic acids I and II.
    Shibutani S; Dong H; Suzuki N; Ueda S; Miller F; Grollman AP
    Drug Metab Dispos; 2007 Jul; 35(7):1217-22. PubMed ID: 17392392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid.
    Stiborová M; Frei E; Schmeiser HH
    Kidney Int; 2008 Jun; 73(11):1209-11. PubMed ID: 18480852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary d-lactate levels reflect renal function in aristolochic acid-induced nephropathy in mice.
    Huang TC; Chen SM; Li YC; Lee JA
    Biomed Chromatogr; 2013 Sep; 27(9):1100-6. PubMed ID: 23553367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute nephrotoxicity of aristolochic acids in mice.
    Sato N; Takahashi D; Chen SM; Tsuchiya R; Mukoyama T; Yamagata S; Ogawa M; Yoshida M; Kondo S; Satoh N; Ueda S
    J Pharm Pharmacol; 2004 Feb; 56(2):221-9. PubMed ID: 15005881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma.
    Boot A; Jiang N; Rozen SG
    Theranostics; 2020; 10(12):5578-5580. PubMed ID: 32373232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of urinary tract carcinoma in aristolochic acid nephropathy.
    Pozdzik AA; Baudoux T; Roumeguere T; Vanherweghem JL; Nortier JL
    Nephrol Dial Transplant; 2012 Jan; 27(1):456. PubMed ID: 22025113
    [No Abstract]   [Full Text] [Related]  

  • 12. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor.
    Pfohl-Leszkowicz A; Tozlovanu M; Manderville R; Peraica M; Castegnaro M; Stefanovic V
    Mol Nutr Food Res; 2007 Sep; 51(9):1131-46. PubMed ID: 17729220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased renal semicarbazide-sensitive amine oxidase activity and methylglyoxal levels in aristolochic acid-induced nephrotoxicity.
    Huang TC; Chen SM; Li YC; Lee JA
    Life Sci; 2014 Sep; 114(1):4-11. PubMed ID: 25107330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aristolochic acid nephropathy: variation in presentation and prognosis.
    Yang L; Su T; Li XM; Wang X; Cai SQ; Meng LQ; Zou WZ; Wang HY
    Nephrol Dial Transplant; 2012 Jan; 27(1):292-8. PubMed ID: 21719716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome-wide analysis of protein alterations in response to aristolochic acids in rat kidney and liver tissues.
    Liu J; Dong W; Wong TY; Qiu C; Wu J; Zhao J; Xia J; Xie S; Song X
    Mol Omics; 2021 Jun; 17(3):405-412. PubMed ID: 34008672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review.
    Gökmen MR; Cosyns JP; Arlt VM; Stiborová M; Phillips DH; Schmeiser HH; Simmonds MS; Cook HT; Vanherweghem JL; Nortier JL; Lord GM
    Ann Intern Med; 2013 Mar; 158(6):469-77. PubMed ID: 23552405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in p38-STAT3-S100A11 signaling after the administration of aristolochic acid I and IVa may account for the disparity in their nephrotoxicity.
    Xian Z; Tian J; Zhao Y; Yi Y; Li C; Han J; Zhang Y; Wang Y; Wang L; Liu S; Pan C; Liu C; Wang D; Meng J; Tang X; Wang F; Liang A
    Phytomedicine; 2023 Jun; 114():154815. PubMed ID: 37062136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I.
    Xue X; Gong LK; Maeda K; Luan Y; Qi XM; Sugiyama Y; Ren J
    Mol Pharm; 2011 Dec; 8(6):2183-92. PubMed ID: 21980933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse.
    Rosenquist TA
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1360-7. PubMed ID: 21429970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the aristolochic acid toxicities in rat kidneys with regulatory networks.
    Wang YY; Li Z; Chen T; Zhao XM
    IET Syst Biol; 2015 Aug; 9(4):141-6. PubMed ID: 26243830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.